1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia
- 1 May 1998
- journal article
- Published by Elsevier in Kidney International
- Vol. 53 (5), 1353-1357
- https://doi.org/10.1046/j.1523-1755.1998.00865.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Intravenous calcitriol normalizes insulin sensitivity in uremic patientsKidney International, 1995
- Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patientsKidney International, 1992
- Glucose and Insulin Metabolism in UremiaNephron, 1992
- Vitamin D3Improves Impaired Glucose Tolerance and Insulin Secretion in the Vitamin D-Deficient Ratin VivoEndocrinology, 1986
- The Influence of Hyperparathyroidism on Glucose Metabolism in Uremia*Journal of Clinical Endocrinology & Metabolism, 1985
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- Lipid abnormalities in uremia, dialysis, and transplantationKidney International, 1981
- Insulin resistance in uremia.Journal of Clinical Investigation, 1981
- Vitamin D Deficiency Inhibits Pancreatic Secretion of InsulinScience, 1980
- Effects of arterial versus venous sampling on analysis of glucose kinetics in manJournal of Applied Physiology, 1976